Gounder, M., Schöffski, P., Jones, R. L., Stacchiotti, S., Demetri, G. D., Cote, G. M., Agulnik, M., Chugh, R., Jahan, T., Gupta, A. A., Chen, T. W., Ratan, R., Dileo, P., Drilon, A., Malouf, G. G., Szanto, A., Gupta, N., Tannir, N. M. (2026). Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study. Nature Communications. https://doi.org/10.1038/s41467-026-69708-2